Venture Life Group (LON:VLG) Posts Quarterly Earnings Results

Venture Life Group (LON:VLG) posted its quarterly earnings results on Tuesday. The company reported GBX 4.10 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.

Venture Life Group Stock Up 3.8%

LON VLG traded up GBX 2.50 during trading on Thursday, reaching GBX 68. 1,257,794 shares of the company’s stock traded hands, compared to its average volume of 278,098. The company has a debt-to-equity ratio of 0.82, a current ratio of 4.71 and a quick ratio of 1.48. The firm has a market cap of £81.63 million, a price-to-earnings ratio of 15.56, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23. The company’s 50 day simple moving average is GBX 67.37 and its two-hundred day simple moving average is GBX 65.08. Venture Life Group has a 12-month low of GBX 52 and a 12-month high of GBX 72.

Insider Activity

In other Venture Life Group news, insider Daniel Wells acquired 38,717 shares of the company’s stock in a transaction dated Wednesday, September 30th. The shares were purchased at an average cost of GBX 65 per share, for a total transaction of £25,166.05. Corporate insiders own 7.52% of the company’s stock.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.